Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome?

Sandra E. Reznik; Amit K. Tiwari; Charles R. Ashby

doi:10.1016/j.phrs.2020.105055

Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome?

Sandra E. Reznik
, Amit K. Tiwari
, Charles R. Ashby

St. John's University
Albert Einstein College of Medicine
University of Toledo

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English
Article number	105055
Journal	Pharmacological Research
Volume	160
DOIs	https://doi.org/10.1016/j.phrs.2020.105055
State	Published - Oct 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.phrs.2020.105055

Cite this

@article{3e3ed50b145f40e39c870578ba0077bb,

title = "Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome?",

author = "Reznik, \{Sandra E.\} and Tiwari, \{Amit K.\} and Ashby, \{Charles R.\}",

year = "2020",

month = oct,

doi = "10.1016/j.phrs.2020.105055",

language = "English",

volume = "160",

journal = "Pharmacological Research",

issn = "1043-6618",

publisher = "Academic Press",

}

TY - JOUR

T1 - Edaravone

T2 - A potential treatment for the COVID-19-induced inflammatory syndrome?

AU - Reznik, Sandra E.

AU - Tiwari, Amit K.

AU - Ashby, Charles R.

PY - 2020/10

Y1 - 2020/10

UR - https://www.scopus.com/pages/publications/85087412314

U2 - 10.1016/j.phrs.2020.105055

DO - 10.1016/j.phrs.2020.105055

M3 - Letter

C2 - 32619723

AN - SCOPUS:85087412314

SN - 1043-6618

VL - 160

JO - Pharmacological Research

JF - Pharmacological Research

M1 - 105055

ER -

Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome?

UN SDGs

Access to Document

Other files and links

Cite this